Vontobel Holding Ltd.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1588340 ZURICH, V8

Position in BBIO

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$1,327,174

-$130,878 QoQ

Shares Held

17,872

-6.2% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vontobel Holding Ltd. holds $92,341,956 across 47 Biotechnology names. BBIO ranks #6 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	83,380	$37,232,503
2	REGN	Regeneron Pharmaceuticals, Inc.	28,794	$22,247,395
3	MRNA	Moderna, Inc.	163,422	$8,301,837
4	BNTX	BioNTech SE	93,107	$8,275,350
5	ALNY	Alnylam Pharmaceuticals, Inc.	5,476	$1,811,842
6	BBIO	BridgeBio Pharma, Inc. This page	17,872	$1,327,174
7	MCRB	Seres Therapeutics, Inc.	138,468	$1,228,211
8	OCUL	Ocular Therapeutix, Inc	135,605	$1,148,574

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,327,174	17,872	-6.2%	Shares	Defined	2026-05-08
2025-12-31	$1,458,052	19,062	+82.6%	Shares	Defined	2026-02-13
2025-09-30	$542,357	10,442	+6.2%	Shares	Defined	2025-10-15
2025-06-30	$424,459	9,830	-67.5%	Shares	Defined	2025-07-23
2024-03-31	$934,278	30,216	-1.9%	Shares	Defined	2024-05-10
2023-12-31	$1,243,840	30,811	-53.6%	Shares	Defined	2024-06-04
2023-09-30	$1,749,834	66,357	-1.8%	Shares	Defined	2024-06-04
2023-06-30	$1,162,014	67,559	-27.1%	Shares	Defined	2024-06-04
2023-03-31	$1,537,297	92,720	-12.2%	Shares	Defined	2024-06-04
2022-12-31	$804,504	105,578	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.